1678P_PR The impact of COVID-19 pandemic on cancer care: A global collaborative study

Jazieh, Abdul Rahman; Akbulut, Hakan; Curigliano, Giuseppe; Rogado, Álvaro; Alsharm, Abdullah; Razis, Evangelia; Mula‐Hussain, Layth; Errihani, Hassan; Khattak, Adnan; Guzman, Roselle De; Mathias, Clarissa; Alkaiyat, Mohammad; Jradi, Hoda; Rolfo, Christian

doi:10.1016/j.annonc.2020.08.2325

Cited by 8 publications

(6 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Particularly, in countries with widespread community transmission of COVID-19, the pandemic forced an abrupt change in how (and in what form) cancer services were delivered to patients [1] . Understandably, international reports on the impact of COVID-19 on access to and through cancer services have been framed within the experience of systems that are dealing with a major COVID-19 morbidity and mortality burden [2][3][4][5] . These reports have illustrated the likelihood that, in a system stretched by the health response to the pandemic, treatment delays appear inexorable and the consequent impact on mortality appears to be stark [3 , 5-12] .…”

Section: Introductionmentioning

confidence: 99%

The impact of the COVID-19 pandemic on cancer diagnosis and service access in New Zealand–a country pursuing COVID-19 elimination

Gurney

Millar

Dunn

et al. 2021

The Lancet Regional Health - Western Pacific

View full text Add to dashboard Cite

Background:The COVID-19 pandemic has disrupted cancer services globally. New Zealand has pursued an elimination strategy to COVID-19, reducing (but not eliminating) this disruption. Early in the pandemic, our national Cancer Control Agency ( Te Aho o Te Kahu ) began monitoring and reporting on service access to inform national and regional decision-making. In this manuscript we use high-quality, nationallevel data to describe changes in cancer registrations, diagnosis and treatment over the course of New Zealand's response to COVID-19. Methods: Data were sourced (2018-2020) from national collections, including cancer registrations, inpatient hospitalisations and outpatient events. Cancer registrations, diagnostic testing (gastrointestinal endoscopy), surgery (colorectal, lung and prostate surgeries), medical oncology access (first specialist appointments [FSAs] and intravenous chemotherapy attendances) and radiation oncology access (FSAs and megavoltage attendances) were extracted. Descriptive analyses of count data were performed, stratified by ethnicity (Indigenous M āori, Pacific Island, non-M āori/non-Pacific). Findings: Compared to 2018-2019, there was a 40% decline in cancer registrations during New Zealand's national shutdown in March-April 2020, increasing back to pre-shutdown levels over subsequent months. While there was a sharp decline in endoscopies, pre-shutdown volumes were achieved again by August. The impact on cancer surgery and medical oncology has been minimal, but there has been an 8% year-todate decrease in radiation therapy attendances. With the exception of lung cancer, there is no evidence that existing inequities in service access between ethnic groups have been exacerbated by COVID-19. Interpretation: The impact of COVID-19 on cancer care in New Zealand has been largely mitigated. The New Zealand experience may provide other agencies or organisations with a sense of the impact of the COVID-19 pandemic on cancer services within a country that has actively pursued elimination of COVID-19. Funding: Data were provided by New Zealand's Ministry of Health, and analyses completed by Te Aho o Te Kahu staff.

show abstract

Section: Introductionmentioning

confidence: 99%

The impact of the COVID-19 pandemic on cancer diagnosis and service access in New Zealand–a country pursuing COVID-19 elimination

Gurney

Millar

Dunn

et al. 2021

The Lancet Regional Health - Western Pacific

View full text Add to dashboard Cite

show abstract

“…is may depend on the threat to the individual and their prevailing conditions as delays may contribute to worsening of cancer and eventually to worse outcomes [87]. If admission to the hospital is considered unavoidable, admissions should be referred to the departments concerned in fighting COVID-19 so that facilities for oncology and radiation therapy remain free of COVID-19 [88]. is is because cancer wards might not be fitted with the requisite quarantine facilities necessary in COVID-19 situations.…”

Section: Resultsmentioning

confidence: 99%

COVID-19 and Cancer Therapy: Interrelationships and Management of Cancer Cases in the Era of COVID-19

Mbugua

Njenga

Odhiambo

et al. 2021

Journal of Chemistry

View full text Add to dashboard Cite

The COVID-19 global epidemic poses this generation’s biggest worldwide public health challenge probably since the 1918 influenza epidemic. Recent reports on two new variants have triggered a dramatic upsurge in research to understand the pandemic, primarily focussing on the virology, triggers, clinical characteristics, and diagnostic tests including the prevention and management of the novel coronavirus. Whilst such studies are important in managing the present medical emergency, there is a need for further work to include interdependencies between the epidemic and other illnesses. This will help in developing effective approaches to treat and manage associated diseases in both the short and the long term. In this regard, people living with cancer are a subgroup that is highly vulnerable to respiratory infections and acute pneumonitis similar to the one caused by the COVID-19 virus. This is because the state of their immunity is compromised due to malignancy and the adverse effects of anticancer treatments. With annual cancer projections rising globally and an estimated 70 percent of all cancer-related deaths occurring in low- and middle-income countries, the patient population with impaired immune systems that could be adversely impacted by COVID-19 is only anticipated to rise. In this review, we delve into the challenges and health risks facing cancer patients and cancer treatment in the COVID-19 context, with suggestions into viable measures which can be taken to minimize exposure to the risk of contracting COVID-19 for this vulnerable subgroup. New mutations and the prospects offered by vaccines development and how they relate to this class of patients are also discussed.

show abstract

“…7,8 Jazieh y cols. 9 entregan datos de este impacto a nivel global a través de un cuestionario electrónico enviado a centros oncológicos (356 centros de 54 países de los seis continentes, que suman 700.000 nuevos pacientes con cáncer al año). La mayoría de ellos (88%) informó dificultades para dar atención durante la pandemia.…”

Section: Introductionunclassified

“…El 46% de los centros informó que más del 10% de sus pacientes había faltado al menos a un ciclo de terapia. 9 Esto también es percibido de manera deletérea por los pacientes. Una encuesta fue enviada en línea a 5.302 pacientes con cáncer para conocer el impacto de COVID-19 en la atención oncológica desde su perspectiva.…”

Section: Introductionunclassified

Impacto de la pandemia por coronavirus (SARS-CoV-2) en el diagnóstico, tratamiento y seguimiento de los pacientes oncológicos

Miranda-Olivares

Lira-Correa

Bermúdez-Valenzuela

et al. 2021

Rev. chil. salud pública

View full text Add to dashboard Cite

El síndrome respiratorio agudo severo por coronavirus (SARS-CoV-2) ha generado una pandemia que ha requerido ajustes significativos en los sistemas de salud mundiales, tanto a nivel hospitalario como ambulatorio. Para patologías crónicas no transmisibles, como las oncológicas, esta pandemia ha tenido repercusiones importantes especialmente a nivel primario de atención. Se ha afectado el manejo oncológico integral, desde la detección precoz, el tratamiento, los exámenes de control y el seguimiento de los pacientes. Entre ellos destaca la disminución, a nivel mundial, del número de procedimientos diagnósticos digestivos, de imágenes, citológicos, quirúrgicos, de tratamiento sistémico, consultas e interconsultas oncológicas. Diversas organizaciones han recopilado cifras de ello y han proyectado cifras de como la disminución de diagnóstico oportuno o el retraso y/o interrupción del tratamiento repercutirán en un aumento de la morbimortalidad. Por ello, han elaborado guías de recomendaciones para minimizar el riesgo de contagio por coronavirus, para retomar a la brevedad el nivel de atención. Esta revisión ejemplifica el impacto de la pandemia de COVID-19 en el manejo habitual de los pacientes con patologías oncológicas, lo que permitirá dimensionar su efecto, así como delinear un plan multidisciplinario de recuperación y puesta al día en el manejo integral de los pacientes oncológicos.

show abstract

1678P_PR The impact of COVID-19 pandemic on cancer care: A global collaborative study

Cited by 8 publications

References 0 publications

The impact of the COVID-19 pandemic on cancer diagnosis and service access in New Zealand–a country pursuing COVID-19 elimination

The impact of the COVID-19 pandemic on cancer diagnosis and service access in New Zealand–a country pursuing COVID-19 elimination

COVID-19 and Cancer Therapy: Interrelationships and Management of Cancer Cases in the Era of COVID-19

Impacto de la pandemia por coronavirus (SARS-CoV-2) en el diagnóstico, tratamiento y seguimiento de los pacientes oncológicos

Contact Info

Product

Resources

About